Chemotherapy-induced Nausea and Vomiting
114
4
4
78
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
40 trials with published results (35%)
Research Maturity
78 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.3%
6 terminated out of 114 trials
92.9%
+6.3% vs benchmark
38%
43 trials in Phase 3/4
51%
40 of 78 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 78 completed trials
Clinical Trials (114)
The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC
Effect of Foot Reflexology On Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)
The Effect of Mandala Technique on Acute Nausea-vomiting and Comfort Level in Cancer Patients
Anti-emetic Prophylaxis With or Without Dexamethasone
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)